Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With NASH
Status:
Terminated
Trial end date:
2018-09-19
Target enrollment:
Participant gender:
Summary
The purpose of the present study is to assess the effects of LMB763 with respect to safety,
tolerability, and on markers of liver inflammation in patients with NASH